Clinical checklists in the selection of mentally retarded males for molecular screening of fragile X syndrome

AUTOR(ES)

Christofolini, Denise M., Lipay, Monica V.N., Ramos, Marco Antonio P., Costa, Silvia S., Bellucco, Fernanda T.S., Nogueira, Sintia I., Kulikowski, Leslie D., Brunoni, Décio, Melaragno, Maria Isabel

FONTE

Genetics and Molecular Biology

DATA DE PUBLICAÇÃO

2007

RESUMO

Fragile X syndrome is the most frequent cause of inherited mental retardation. The phenotype in this syndrome is quite variable and less conspicuous in younger patients, making clinical diagnosis difficult and thus making molecular diagnosis necessary. The use of clinical checklists in mentally retarded individuals can help selecting patients to be given priority in the molecular investigation for the fragile-X mutation in the FMR1 gene. We evaluated two clinical checklists in a sample of 200 Brazilian male patients with mental retardation. The highest scores in the two checklists concentrated among the 19 males (9.5%) found to carry full mutations. Our results confirm the importance of fragile-X checklists as a clinical tool in the study of mentally retarded patients.

Documentos Relacionados

• Molecular screening for proximal 15q abnormalities in a mentally retarded population.
• Direct analysis of the FMR-1 gene provides an explanation for an exceptional case of a fragile X negative, mentally retarded male in a fragile X family.
• Fragile X founder effect and distribution of CGG repeats among the mentally retarded population of Andalusia, South Spain
• Molecular heterogeneity of the fragile X syndrome.
• Cloning of the gene for the fragile X syndrome: implications for the clinical geneticist.